Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gruber

Showing results (261-270 of 355) with videos related to

Pageof 36
Sort By:
The Journal of Infectious Diseases|November 17, 1998
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F proteinR Malley, J DeVincenzo, O Ramilo, et al.
Clinical and Vaccine Immunology : CVI|December 16, 2014
Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in MexicoJuan Carlos Tinoco, Christine Juergens, Guillermo M Ruiz Palacios, et al.
The Journal of Infectious Diseases|April 12, 2024
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and RevaccinationEdward E Walsh, Ann R Falsey, Agnieszka M Zareba, et al.
Vaccine|May 8, 2016
Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and olderRobert W Frenck, Anne Fiquet, Alejandra Gurtman, et al.
The Pediatric Infectious Disease Journal|September 29, 2006
Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infectionsShai Ashkenazi, Andre Vertruyen, Javier Arístegui, et al.
Journal of Agricultural and Food Chemistry|January 7, 2004
Acrylamide formation mechanism in heated foodsDavid V Zyzak, Robert A Sanders, Marko Stojanovic, et al.
The Journal of Infection|August 14, 2016
Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 studyHelen Marshall, Michael Nissen, Peter Richmond, et al.
Vaccine|November 17, 2023
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of ageShane Christensen, Salim Bouguermouh, Kumar Ilangovan, et al.
Open Forum Infectious Diseases|December 8, 2025
T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in ChildrenIsabel Vogler, Stephanie Renken, Rolf Hilker, et al.
The Pediatric Infectious Disease Journal|March 27, 2024
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy InfantsShelly Senders, Nicola P Klein, Noor Tamimi, et al.
Pageof 36

Showing results (261-270 of 355) with videos related to

Sort By:
Pageof 36
The Journal of Infectious Diseases|November 17, 1998
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F proteinR Malley, J DeVincenzo, O Ramilo, et al.
Clinical and Vaccine Immunology : CVI|December 16, 2014
Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in MexicoJuan Carlos Tinoco, Christine Juergens, Guillermo M Ruiz Palacios, et al.
The Journal of Infectious Diseases|April 12, 2024
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and RevaccinationEdward E Walsh, Ann R Falsey, Agnieszka M Zareba, et al.
Vaccine|May 8, 2016
Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and olderRobert W Frenck, Anne Fiquet, Alejandra Gurtman, et al.
The Pediatric Infectious Disease Journal|September 29, 2006
Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infectionsShai Ashkenazi, Andre Vertruyen, Javier Arístegui, et al.
Journal of Agricultural and Food Chemistry|January 7, 2004
Acrylamide formation mechanism in heated foodsDavid V Zyzak, Robert A Sanders, Marko Stojanovic, et al.
The Journal of Infection|August 14, 2016
Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 studyHelen Marshall, Michael Nissen, Peter Richmond, et al.
Vaccine|November 17, 2023
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of ageShane Christensen, Salim Bouguermouh, Kumar Ilangovan, et al.
Open Forum Infectious Diseases|December 8, 2025
T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in ChildrenIsabel Vogler, Stephanie Renken, Rolf Hilker, et al.
The Pediatric Infectious Disease Journal|March 27, 2024
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy InfantsShelly Senders, Nicola P Klein, Noor Tamimi, et al.
Pageof 36